ASRT vs TRV · rev $125.0M vs P/E 14, rev $48.83B
Assertio Therapeutics Inc (ASRT) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported TRV revenue for 2025-12-31 was $48.83B. Net income was $6.29B. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
ASRT currently screens at market cap $151.5M. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the ASRT and TRV stock pages for the full models.
Not investment advice.